RxDoctor Payments DataLook up a doctor →

EYSUVIS: payments to doctors

Payments that named EYSUVIS as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$2.6M
Providers
10,720
Transactions
33,057
Average per transaction
$79

The per-transaction average — $79 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,720 providers the average total is $245, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Kala Pharmaceuticals, Inc.$2,373,77990.4%
Alcon$250,8299.6%
Alcon Research LLC$830.0%
← All drugs & devices